

Health Care: Drugs
Pain Therapeutics Inc. (PTIE: NASDAQ)
$2.89 0.09 | 3.21%
05/17/13 - 04:00 PM ET
556.54K / 313.10K
Vol / Avg. Vol:
2.82 / 2.80
Open / Prev. Close:
2.72 - 2.90
Today's Range:
Portfolios with PTIE
Latest PTIE Headlines from TheStreet
More Financial News for PTIE
Press Releases for PTIE
- Faruqi & Faruqi, LLP Is Investigating Pain Therapeutics Inc. On Behalf Of Its Shareholders (PTIE) - PR Newswire 06.27.12 | 07:06 am
- Harwood Feffer LLP Announces Investigation Of Pain Therapeutics, Inc. - Business Wire 01.06.12 | 03:01 pm
- The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Pain Therapeutics, Inc. Of Class Action Lawsuit And The Deadline Of January 31, 2012 To Seek A Lead Plaintiff Position - Business Wire 01.05.12 | 03:01 pm
- Faruqi & Faruqi, LLP Announces Investigation Of Pain Therapeutics, Inc. - Business Wire 12.05.11 | 07:12 pm
- Bronstein, Gewirtz & Grossman, LLC Investigates Miller Energy Resources, Inc. - Business Wire 08.26.11 | 05:08 pm
- Pfizer Receives Complete Response Letter From FDA For REMOXY® - PR Newswire 06.24.11 | 08:06 am
- FDA Complete Response Letter Received For REMOXY - Business Wire 06.24.11 | 08:06 am
- REMOXY® New Drug Application Accepted By The FDA With PDUFA Goal Date Of June 23, 2011 - PR Newswire 01.27.11 | 08:01 am
- REMOXY® New Drug Application Resubmitted - PR Newswire 12.27.10 | 07:12 am
See All Press Releases
Partner Headlines for PTIE